{
    "type": "ETP",
    "ucits": false,
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": [
        "Inverse exposure",
        "Daily compounding effect",
        "Counterparty risk from swaps",
        "High volatility risk",
        "Short-term trading requirement"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree FTSE 250 1x Daily Short is a synthetic ETP that uses swaps to achieve its inverse exposure to the FTSE 250 index. Key complexity indicators include: 1) The use of swaps for replication, creating counterparty risk; 2) The inverse (-1x) daily performance structure which introduces compounding effects over time; 3) The high risk rating of 7/7 indicating significant potential for loss; 4) The requirement for sophisticated investors who understand daily rebalancing and compounding effects; 5) The product's structure as a collateralized debt security rather than a traditional fund. The KIID explicitly states 'You are about to purchase a product that is not simple and may be difficult to understand,' which is a strong indicator of complexity under MiFID II. The daily reset mechanism and potential for significant tracking error over longer periods add to the complexity.",
    "confidence": 95,
    "counter_argument": "Some might argue this could be considered non-complex because it's a simple -1x inverse product without additional leverage. However, the synthetic replication via swaps, the daily compounding effect that makes long-term performance unpredictable, and the high risk profile outweigh this argument. The product's structure as a debt security rather than a fund, combined with the explicit warnings about complexity in the documentation, clearly place it in the complex category under MiFID II.",
    "risk_level": 7,
    "primary_reasoning": "The product's synthetic replication using swaps, inverse exposure with daily compounding effects, and high risk profile (7/7) make it complex under MiFID II regulations. The explicit warnings about the product's complexity in the documentation further support this classification."
}